de pres sion, and phys i cal pain in var i ous pa tient co horts (4) . L-tryptophan has also been used for main te nance treatment of bi po lar II dis or der (5) . There are no re ported stud ies of its use in pa tients with fibromyalgia and bi po lar dis or der. In a dou ble-blind, pla cebo-con trolled study, 5-hydroxytryptophan given to 50 pa tients with fibromyalgia in a dos age of 300 mg daily for 30 days sig nif i cantly im proved var i ous clin i cal pa ram e ters, in clud ing sleep pat terns, anx i ety, and ten der points (6) .
The use of an ti de pres sants alone or combined with mood sta bi liz ers for Ms A clearly re sulted in an un sta ble ill ness course; how ever, as noted, the use of anti de pres sants may be un avoid able in patients who also suf fer from fibromyalgia. Poor sleep qual ity due to fibromyalgia is an other fac tor that likely con trib uted to in creased cy cle frequency. This pa tient de vel oped a clear mixed state that re solved when the dosage was re duced, which sug gests that L-tryptophan dos age in pa tients with rapid-cy cling bi po lar dis or der should be ti trated up ward with cau tion.
Verinder Sharma, MB, BS, FRCPC Cari Barrett MSW, CSW London, Ontario

Laryngeal Dystonia in Psychiatry
Dear Ed i tor:
Antipsychotic med i ca tions, while helpful treat ments for acutely ill pa tients, may cause se ri ous side ef fects that include akathesia, parkinsonism, and dystonia. Med i ca tions other than neuroleptics can af fect do pa mine re ceptors and pro duce dystonic re ac tions. The spec trum of dystonic re ac tions can include torticollis, retrocollis, oculogyric cri sis, and la ryn geal dystonia (1) (2) (3) (4) . The fol low ing case high lights the dan ger of la ryn geal dystonia, which can be po tentially le thal, yet may not be con sid ered as an eti ol ogy.
A 17-year-old fe male pa tient with a benign past med i cal and psy chi at ric history pre sented with symp toms of vi sual scotomata, nau sea, and near syn cope. A com plete syn cope workup was ini ti ated, which was neg a tive. The pa tient was given metoclopramide for her nau sea. On day 2, she com plained of dif fi culty in swal low ing. Fol low ing a nor mal neu rolog i cal ex am i na tion and blood gas test, the pa tient was di ag nosed with con version re ac tion. Her base line his tri onic per son al ity style and a re cent re la tionship cri sis sup ported this di ag no sis. Her symp toms waxed and waned over the next 12 hours. She then de vel oped retrocollis, se vere shoul der pain, and extreme dif fi culty in swal low ing, and she be came in creas ingly anx ious. She was treated with 2 mg of benzotropine IM. Within 5 to 10 min utes, her symp toms com pletely re solved. She was con tin ued on benzotropine 2 mg twice daily for 2 weeks; it was then ta pered and dis con tin ued.
It is hy poth e sized that dystonia re sults from acute do pa mine block ade at the level of the basal gan glia. Re ac tions occur af ter ex po sure to do pa mine-blocking agents, in clud ing compazine, phenergan, and metoclopramide. Dystonic re ac tions have also been reported with se ro to nin reuptake in hib itors and lith ium. There are many types of dystonia (for ex am ple, oculogyric cri sis, retrocollis, and tortocollis) that are easily rec og nized by most cli ni cians. Laryn geal dystonia, how ever, is more prob lem atic be cause it is much less common, and it is po ten tially life threat ening. (5) La ryn geal dystonia is an un com mon extrapyramidal syn drome that can be seen with do pa mine-block ing agents. It can pres ent with neck pain and trou ble swal low ing and, in se vere cases, can com pro mise a pa tient's air way. These pa tients' symp toms are of ten la beled psy cho genic, and a psy cho genic con flict is of ten found, even if it is not of pri mary im por tance. This can lead to a de layed di ag no sis, as was ev i dent in this case (6) . It is es sen tial to keep a high de gree of clin i cal sus pi cion for this syn drome in pa tients who pres ent with dysarthria or dysphagia af ter be ing ex posed to a do pamine-block ing agent, so that treat ment can be ini ti ated in a timely fash ion.
